Abstract:These prospective data support that cardiovascular disease (CVD) risk factors are strongly associated with the subsequent development of common upper extremity musculoskeletal disorders (MSDs). Risks rise with both magnitude of CVD risks and numbers of MSDs developed. Research into secondary prevention efforts appears warranted.
“…This approach—a multimorbidity approach—reflects how patients experience illness and therefore how they interact with the health system. A cancer diagnosis, for example, is strongly associated with a risk of first-onset mental health conditions; and patients with poor cardiovascular health are substantially more likely to develop musculoskeletal disorders 12. More than a quarter of the adult population in England are currently living with two or more long term conditions, and this is forecast to increase over the coming decades 3.…”
“…This approach—a multimorbidity approach—reflects how patients experience illness and therefore how they interact with the health system. A cancer diagnosis, for example, is strongly associated with a risk of first-onset mental health conditions; and patients with poor cardiovascular health are substantially more likely to develop musculoskeletal disorders 12. More than a quarter of the adult population in England are currently living with two or more long term conditions, and this is forecast to increase over the coming decades 3.…”
Learning objective: After completing this activity, physicians should be better able to assess the potential risks of common treatments toward the development of interstitial lung disease in patients with rheumatoid arthritis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.